Ozempic and GLP-1 drugs: news and trends
Follow topicGLP-1 drugs (Ozempic, Wegovy, Mounjaro) in the news: studies, regulators, prices and the market. A review of media coverage, not medical advice.
Key facts
- In the last 31 days, 3,482 articles about Ozempic and GLP-1 drugs appeared in 1,270 outlets in 41 languages.
- Coverage peaked on October 28 with 810 articles in a day. In the second half of the period, coverage was up 135% versus the first half.
- Countries mentioned most often in this coverage: United States, United Kingdom, Denmark.
- Main languages of coverage: English, Spanish, Russian.
- Average tone of coverage is negative (-2.0 on a scale from −10 to +10).
Last 30 days · 3,482 articles · 41 languages · 1,270 sources · updated 2026-11-12 11:30 UTC
Articles, 30 days
3,482
41 languages
Sources
1,270
iheart.com
Average tone
-1.98
negative
Top country
United States
1,142 mentions
Volume
Articles per 10,000 across all sources, daily
10-1311-12
Where it happens
United States
1,142
United Kingdom
400
Denmark
161
Brazil
154
France
137
Italy
124
Germany
99
India
96
Australia
96
China
80
Who covers it
English · 2,493Spanish · 177Russian · 125Portuguese · 122German · 114French · 100Italian · 76ell · 48Chinese · 34hrv · 26
- iheart.com831
- aol.com32
- medscape.com28
- manilatimes.net27
- endocrinologyadvisor.com24
- news-medical.net24
- indiatimes.com23
- dailymail.com22
- medicaldaily.com19
- globo.com19
Latest articles
- Deloitte Cuts GLP-1 Weight Loss Coverage As Healthcare Costs Risebusinessinsider.com · English · 11-12 11:30neutral
- Doctors caution against stopping weight-loss drugs over vision-loss riskbusiness-standard.com · English · 11-12 11:30negative
- Regulador obriga Ozempic, Wegovy e Mounjaro a ter aviso nos EUA sobre risco de perda de visãosapo.pt · Portuguese · 11-12 11:15negative
- Eli Lilly, prima companie farmaceutică care obține aprobarea unui medicament pentru slăbit GLP-1 în Chinaagerpres.ro · ron · 11-12 11:15neutral
- Hervolution ApS: HERVolution Therapeutics Appoints Professor Jens Juul Holst, Co-discoverer of GLP-1, to Scientific Advisory Boardfinanznachrichten.de · English · 11-12 11:00positive
- 禮來在中國獲批首款減肥藥GLP-1口服藥｜METROHK.com.hkmetrohk.com.hk · Chinese · 11-12 11:00neutral
- If you're on weight loss drugs and have 'low activity levels' this is what you ned to knowhellomagazine.com · English · 11-12 11:00positive
- US FDA flags blindness risk from GLP-1 drugs: What patients should knowbusiness-standard.com · English · 11-12 10:45negative
- 【美股盘前】英伟达跌超6%；存储、光通信股下跌，SK海力士跌超3%；台积电跌1.85%，美银预计其2027年资本开支或高达900亿美元；礼来涨超2%，口服GLP-1减重药获批在国内上市nbd.com.cn · Chinese · 11-12 10:45positive
- HERVolution Therapeutics Appoints Professor Jens Juul Holst, Co-discoverer of GLP-1, to Scientific Advisory Boardprnewswire.com · English · 11-12 10:45positive
- Diabete di tipo 2, chi interrompe i GLP-1 ha un rischio doppio di infarto, ictus o mortecomunicati-stampa.net · Italian · 11-12 10:30negative
- Стройность обернется проблемами: врач предупредил о скрытых рисках уколов для похуденияabnews.ru · Russian · 11-12 10:30negative
- Weight-loss drug boom threatens insulin supply, experts warnbdnews24.com · English · 11-12 10:30neutral
- Aspen wins approval for generic semaglutide in South Africa, Brazilsundayworld.co.za · English · 11-12 10:00neutral
- Исследование: тирзепатид сильнее семаглутида снижает безжировую массу телаvedomosti.ru · Russian · 11-12 10:00neutral
- Diyabet hastalarında GLP-1 ilaçlarını bırakmak kalp krizi, felç ve ölüm riskini ikiye katlayabilir - Haberlerhaberturk.com · Turkish · 11-12 09:45neutral
- Eli Lilly first to have GLP-1 pill approved in Chinarte.ie · English · 11-12 09:45negative
- GLP-1 ilaçların olası göz riski FDA uyarısıyla yeniden gündeme geldihaberler.com · Turkish · 11-12 09:30negative
- Kelvin Kinuthia Reacts To FDA Blindness Warning On Ozempic Surgeryghafla.co.ke · English · 11-12 09:15neutral
- La rara enfermedad que provoca el Ozempic, según la FDA: podrías perder la visióneldiariony.com · Spanish · 11-12 08:30negative
- La FDA alerta sobre un posible riesgo de desarrollar neuropatía óptica isquémica asociado a los medicamentos GLP-1diariodesevilla.es · Spanish · 11-12 08:15negative
- De Ozempic a Loniten, la estética detrás de la escasez de medicamentosdiariovasco.com · Spanish · 11-12 08:15negative
- Φάρμακα GLP-1 και Όραση: Η Θέση του ΕΟΦ για τον Κίνδυνο της Νευροπάθειας NAIONtopontiki.gr · ell · 11-12 08:00negative
- К создателям "Оземпика" и его аналогов в США подали свыше 4 тысяч исков1prime.ru · Russian · 11-12 07:45negative
- Ozempic nie tylko na odchudzanie? Naukowcy zbadali ukryte korzyści terapii GLP-1newsweek.pl · Polish · 11-12 07:30neutral
Headlines in the original language. Translation, AI summary and contested stories arrive with AI labelling.
Follow the topic «Ozempic and GLP-1 drugs»
Weekly: what changed, new contested stories, summary. No sign-up.